Revenue | ₹378.22Cr |
Net Profits | ₹77.59Cr |
Net Profit Margins | 20.51% |
Procter & Gamble Health Ltd’s revenue jumped 20.56% since last year same period to ₹378.22Cr in the Q3 2025-2026. On a quarterly growth basis, Procter & Gamble Health Ltd has generated 14.66% jump in its revenue since last 3-months.
Procter & Gamble Health Ltd’s net profit fell -14.64% since last year same period to ₹77.59Cr in the Q3 2025-2026. On a quarterly growth basis, Procter & Gamble Health Ltd has generated -12.37% fall in its net profits since last 3-months.
Procter & Gamble Health Ltd’s net profit margin fell -29.2% since last year same period to 20.51% in the Q3 2025-2026. On a quarterly growth basis, Procter & Gamble Health Ltd has generated -23.57% fall in its net profit margins since last 3-months.
The revenue for Procter & Gamble Health Ltd in the Q3 results 2025 was ₹378.22Cr.
The net profit for Procter & Gamble Health Ltd in the Q3 results 2025 was ₹77.59Cr.
The net profit margin for Procter & Gamble Health Ltd in the Q3 results 2025 was 20.51%.
The revenue for Procter & Gamble Health Ltd in the Q3 results 2024 was ₹313.73Cr.
The net profit for Procter & Gamble Health Ltd in the Q3 results 2024 was ₹90.90Cr.
The net profit margin for Procter & Gamble Health Ltd in the Q3 results 2024 was 28.97%.